Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 <li /> Compa ...
Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
GlobalData on MSN4d
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trialA Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...
A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...
However, plain film radiographs provide poor visualization of the ethmoid sinus due to density averaging. Plain films are therefore useful for diagnosing frontal and maxillary sinus disease but ...
Different RTIs were analysed separately, and this paper focuses on patients with acute sinusitis. Methods, design and patients: This was an open-label, prospective, uncontrolled, post-marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback